Your browser doesn't support javascript.
loading
Research progress of Phyllanthi Fructus and prediction of its Q-markers / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 5533-5544, 2021.
Artigo em Chinês | WPRIM | ID: wpr-921735
ABSTRACT
Phyllanthi Fructus, a unique Chinese and Tibetan medicinal plant with both edible and medical values, has high potential of cultivation and development. The resources of Phyllanthi Fructus in China are rich, mainly distributed in Yunnan, Sichuan, Fujian, Guangdong, Guangxi, etc. Phyllanthi Fructus is widely used in the clinical practice of Chinese medicine and plays an important role in Tibetan medicine, Uyghur medicine, Yi medicine, and Mongolian medicine. Phyllanthi Fructus mainly contains phenolic acids,tannins, terpenes, sterols, fatty acids, flavonoids, amino acids and other compounds. Modern pharmacological studies show that Phyllanthi Fructus has antioxidant, anticancer, blood lipid-lowering, liver protective, antimicrobial, anti-inflammatory, and immune regulatory activities. In this paper, the research status of Phyllanthi Fructus was reviewed from the aspects of herbal textual research,chemical composition, and pharmacological action. The quality markers(Q-markers) of Phyllanthi Fructus were predicted and analyzed from the aspects of biogenic pathway, specificity and measurability of chemical components, efficacy, properties, new clinical uses, drug-food homology, and transformation of polyphenols. The results will provide a scientific basis for the quality control, quality evaluation, and standard formulation of Phyllanthi Fructus.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Controle de Qualidade / Medicamentos de Ervas Chinesas / China / Medicina Tradicional Tibetana / Frutas Tipo de estudo: Estudo prognóstico País/Região como assunto: Ásia Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2021 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Controle de Qualidade / Medicamentos de Ervas Chinesas / China / Medicina Tradicional Tibetana / Frutas Tipo de estudo: Estudo prognóstico País/Região como assunto: Ásia Idioma: Chinês Revista: China Journal of Chinese Materia Medica Ano de publicação: 2021 Tipo de documento: Artigo